This article refers to:
Erratum
The 153 patients described in this paper [Citation1] are the same as those described in two previously reported studies [Citation2,Citation3], which were referenced. However, the authors now see that it was not made sufficiently clear to readers that background data on the patients had been published before. This error decreases the amount of novel information presented in this paper but does not, in the authors’ view, affect the paper’s main findings. The authors would like to apologise for any inconvenience caused.
References
- Hanevik HI, Hilmarsen HT, Skjelbred CF, et al. Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype. Gynecol Endocrinol 2012;28:845–9
- Hanevik HI, Hilmarsen HT, Skjelbred CF, et al. A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online 2011;23:97–104
- Hanevik HI, Hilmarsen HT, Skjelbred CF, et al. Single nucleotide polymorphisms in the anti-Mullerian hormone signalling pathway do not determine high or low response to ovarian stimulation. Reprod Biomed Online 2010;21:616–23